Floatz logo

Dexborneol

Mechanical Thrombectomy

Beijing Tiantan HospitalSmall moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Mechanical Thrombectomy cohort.

Asset / SponsorPhaseRating
LABETALOL
ProMedica Health System
Phase 3BB
Hydralazine
ProMedica Health System
Phase 3BB
Lipitor
Zhongda Hospital
Phase 4BB
Clevidipine
ProMedica Health System
Phase 3BB
Compound Edaravone
Beijing Tiantan Hospital
Phase 3BB
Enalapril
Hamilton Health Sciences Corporation
Phase 2B
3-N-BUTYLPHTHALIDE
Hui-Sheng Chen
N/AD

Same molecule, other indications

Dexborneol is also rated in:

Acute Ischemic StrokeDormant
BB
Indicative ·
66 / 100
View asset →
Active MalignanciesDormant
BB
Indicative ·
65 / 100
View asset →
Phase IIIDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →